Ephraim Fuchs

Director at Iyuda Therapeutics.

Earliest Form D on file: Apr 2026

Filed Apr 6, 2026

Iyuda Therapeutics

Off-the-shelf donor cell therapy for cancer

Biotech, Owings Mills MD

Named, Director.

$600K

sold of $600K offered

Network

At Iyuda Therapeutics

1 person

Robert Tennant
Executive Officer, signed as Chief Executive Officer